The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy

Sosan Mohammadi Kebar, Afshan Shargi, Bahman Bashardoust, Manouchehr Iranparvar, Hossein Fekri * , Afshin Habibzadeh

Cited by CrossRef: 3

1- AL-sofi E, AL-Attar H. Determination of cumulative glucose levels HbA1C and some biochemical variables in the serum of Diabetic nephropathy patients. RB. 2022;7(2):1 [Crossref]

2- Zhao H, Ramirez G. Preliminary Study on the Evaluation of Multimodal Effects of Type 2 Diabetic Nephropathy. Scientific Programming. 2021;2021:1 [Crossref]

3- Grădișteanu Pîrcălăbioru G, Chifiriuc M, Stoica R. SEVELAMER CARBONATE MODULATES THE NLRP3 AND NLRP6 INFLAMMASOME EXPRESSION IN PATIENTS WITH DIABETIC NEPHROPATHY. Roum Arch Microbiol Immunol. 2021;80(2):125 [Crossref]